Atlas Trials

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Clinical trial NCT02709512 · COMPLETED

Trial details

NCT number
NCT02709512
Sponsor
Polaris Group
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Mesothelioma
Start date
2017-08-01
Primary completion
2022-08-15
Enrollment
249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.